Real-World Experience with Anti-CGRP Pathway Monoclonal Antibodies in a Large United States Healthcare Plan: Results of the Migraine Signature Study. - Buse, Dawn C.; Lipton, Richard B.; Urman, Robert; Vaidya, Shruti J.; Robinson, Sarah C.; Jacobson, Alice S.; Scott, Alexandra B.; Bensink, Mark E.; Pressman, Alice R. (Neurology & Therapy, 2026)